Introduction
============

Intraoperative neurophysiologic monitoring (IONM) is a rapidly advancing modality commonly used in spinal surgery.[@JR1500066-1] [@JR1500066-2] [@JR1500066-3] Although almost universally employed during spinal deformity surgery, the indications for monitoring decompressive procedures are more controversial.[@JR1500066-4] Some argue against the use of IONM in cervical decompression altogether.[@JR1500066-4]

The sensitivity of combined sensory and motor modality neurophysiologic monitoring may approach 100%, although sensitivities as low as 43% have been reported.[@JR1500066-5] Somatosensory evoked potentials, although advantageous because they can be monitored continuously, rely on signal averaging over time, and signal decreases may significantly lag behind transcranial motor evoked potential (MEP) changes.[@JR1500066-6] Monitoring MEP may provide earlier detection of neurologic injury and is associated with high sensitivity.[@JR1500066-7] However, MEPs cannot be monitored continuously, may induce patient movement, and are adversely affected by a variety of factors such as inhaled anesthetic agents.[@JR1500066-8]

We recently reported high sensitivity of MEP changes in predicting postoperative deficits in patients undergoing surgery for degenerative cervical and thoracic myelopathy. However, the performance varies based on risk factors such as patient comorbidities, age, and preoperative neurologic function.[@JR1500066-9] Few studies have focused on the use of IONM in patients with myelopathy due to nondegenerative causes. In this study, we analyzed a group of consecutive patients with cervical and cervicothoracic myelopathy secondary to both degenerative and nondegenerative causes who were treated surgically by the authors at a single center (University of California, San Francisco) over the course of 1 year.

Materials and Methods
=====================

Data Collection
---------------

We routinely use IONM on all cervical spine surgeries at our institution. The study was approved by the University of California, San Francisco Institutional Review Board (11-07069). Cases eligible for this study were identified by first screening our IONM database for all the operations performed in the University of California, San Francisco Department of Neurological Surgery from January 1 to December 31, 2011. The hospital records and operative reports of all patients who underwent spine procedures were examined. All patients with either degenerative cervical spondylotic myelopathy (CSM) or myelopathy of nondegenerative causes who underwent cervical or cervicothoracic decompressive operations with IONM during that time were included in our study. Patients with intramedullary spinal cord tumors were excluded. All patients consented for IONM as part of the surgical informed consent process. The patient demographics were obtained from the hospital and clinic charts. Pre- and postoperative neurologic function data was extracted from chart documentation of the neurosurgeon\'s objective examination, including the Medical Research Committee--validated motor scale, sensory disturbance, and evidence of hyperreflexia or pathologic reflexes. To capture the postoperative neurologic deficits, the hospital chart was reviewed until the day of discharge. In addition, the outpatient clinic charts were also reviewed for an average of 6 months. The postoperative neurologic deficit was defined as new or worsening motor weakness on the Medical Research Committee scale after surgery. The IONM alerts were extracted from the IONM report. A significant MEP alert was defined as an abrupt decrease in peak-to-peak amplitude \> 50% for more than three successive trials over a 1- to 3-minute period.

Recording of Intraoperative Motor Evoked Potential Changes
----------------------------------------------------------

Transcranial MEPs were generated by multipulse transcranial electrical stimulation (0 to 800 V, 50- to 75-μs pulse duration, 0 to 9 pulses at 1 to 3 ms) delivered to electrodes placed over the motor cortical regions at C3 and C4 using a Cadwell (Kennewick, Washington, United States) TCS-4 constant voltage stimulator. In addition, the electromyography responses were recorded from needle electrodes placed bilaterally in the deltoid (axillary nerve, C5--C6), biceps (musculocutaneous nerve, C5--C7), triceps (radial nerve, C6--C8), and thenar and hypothenar eminences of the hand (C8--TI). The waveforms were recorded on a commercially available Cadwell (model Elite or Cascade) neurophysiology workstation.

Statistical Analysis
--------------------

A true-positive result was defined as presence of an intraoperative neurophysiologic MEP alert during surgery followed by a neurologic deficit in the postoperative period. Conversely, a true-negative result was defined as the absence of MEP alerts during surgery and the lack of a new neurologic deficit after surgery. A false-positive result was defined as the presence of a persistent nonreversible MEP alert during surgery that was not followed by a neurologic deficit. A false-negative result was defined as the absence of MEP alerts during the operation followed by a new neurologic deficit. The sensitivity was calculated as true-positives / true-positives + false-negatives. The specificity was calculated as true-negatives / true-negatives + false-positives. The associations between IONM of MEP changes and new postoperative neurologic deficits were analyzed by Fisher exact test. Receiver operating characteristic curves were generated to assess the predictive value of IONM of MEP alerts in patients with degenerative CSM and CSM of nondegenerative pathology. The ability of IONM of MEPs to discriminate new postoperative deficits was determined by calculating the area under the receiver operating characteristic curve (AUC) for patients with CSM and patients with CSM of nondegenerative pathology. All analyses were performed using PASW 18.0 Statistics software (SPSS, Inc., Chicago, Illinois, United States), and *p* values less than 0.05 were considered statistically significant.

Results
=======

Patient Demographics
--------------------

During the study period, 144 patients underwent surgery for cervical and cervicothoracic myelopathy. The mean age was 63 years (range 29 to 92) and 48 were women (33%). Myelopathy was caused by degenerative spondylosis in 102 patients (71%) and nondegenerative pathology in 42 (29%). In the nondegenerative group, extramedullary tumors caused myelopathy in the majority of the cases, followed by infection, trauma, and inflammatory processes. Of the tumors, 8 were schwannomas ([Fig. 1](#FI1500066-1){ref-type="fig"}), 8 were metastatic lesions, 4 were meningiomas, 2 were hemangiomas, 1 was a chordoma, and 1 was a neurofibroma. We did not include any intramedullary spinal cord tumors.

![Preoperative imaging in a patient with cervical myelopathy of nondegenerative pathology. An 80-year-old man presented with 6-month history of bilateral upper extremity weakness and numbness. (A, B) T1-weighted magnetic resonance imaging with contrast revealed an enhancing lesion extending from the neural foramen into the spinal canal. (C, D) T2-weighted magnetic resonance imaging was notable for significant cord compression and the absence of hyperintensity in the spinal cord. The patient was taken to the operating room for resection of this lesion, and pathology confirmed the diagnosis of schwannoma.](10-1055-s-0035-1565258-i1500066-1){#FI1500066-1}

The degenerative CSM and nondegenerative cervical myelopathy groups were similar with respect to age and preoperative T2-weighted magnetic resonance imaging cord signal abnormality ([Table 1](#TB1500066-1){ref-type="table"}). There were significantly more women and more preoperative motor deficits in the nondegenerative group. There were significantly fewer cervical lesions in the nondegenerative group. There were significantly fewer anterior operations and fewer instrumented operations in the nondegenerative group.

###### Clinical, pathologic, and surgical characteristics of the 144 patients in the study population

                               Degenerative CSM (*n* = 102), *n* (%)   CSM from nondegenerative causes (*n* = 42), *n* (%)   *p* Value
  ---------------------------- --------------------------------------- ----------------------------------------------------- -----------
  Age (y), mean                64                                      60                                                    0.13
  Sex                                                                                                                        
   Female                      28 (28)                                 20 (48)                                               0.03
  Pathology                                                                                                                  
   Tumor                       --                                      24 (57)                                               --
   Infection                                                           12 (29)                                               
   Trauma                                                              5 (12)                                                
   Inflammatory                                                        1 (2)                                                 
  Level                                                                                                                      
   Cervical                    96 (94)                                 19 (45)                                               \<0.001
   Cervicothoracic             1 (1)                                   3 (7)                                                 
   Thoracic                    5 (5)                                   20 (48)                                               
  Abnormal T2 signal                                                                                                         
   Yes                         48 (51)                                 22 (54)                                               0.85
  Preoperative motor deficit                                                                                                 
   Yes                         57 (56)                                 33 (83)                                               0.002
  Surgical approach                                                                                                          
   Anterior                    25 (25)                                 0 (0)                                                 0.001
   Posterior                   72 (71)                                 37 (88)                                               
   Anterior + posterior        5 (5)                                   5 (12)                                                
  Instrumentation                                                                                                            
   Yes                         97 (95)                                 27 (64)                                               \<0.001

Abbreviation: CSM, cervicothoracic spondylotic myelopathy.

Intraoperative Motor Evoked Potential Changes and New Neurologic Deficits
-------------------------------------------------------------------------

The discrimination of IONM of MEP alerts was assessed to determine their ability to identify patients who incur new postoperative deficits. Among the patients with degenerative CSM, the model performed well for predicting postoperative deficits with an AUC of 0.826 ([Table 2](#TB1500066-2){ref-type="table"}). This result was better than the prediction in patients with CMS of nondegenerative causes, although it did not reach statistical significance (AUC 0.538, *p* = 0.16, [Table 3](#TB1500066-3){ref-type="table"}).

###### Association between intraoperative MEP alerts and new postoperative neurologic deficits in patients with cervicothoracic spondylotic myelopathy

                      MEP alert (*n* = 11), *n* (%)   No alert (*n* = 91), *n* (%)
  ------------------- ------------------------------- ------------------------------
  New motor deficit                                   
   Yes                5 (45)                          2 (2)
   No                 6 (55)                          89 (98)

Abbreviation: MEP, motor evoked potential.

Note: *p* \< 0.001; sensitivity 71%; specificity 94%.

###### Association between intraoperative MEP alerts and new postoperative neurologic deficits in patients with nondegenerative causes of myelopathy

                      MEP alert (*n* = 11), *n* (%)   No alert (*n* = 31), *n* (%)
  ------------------- ------------------------------- ------------------------------
  New motor deficit                                   
   Yes                1 (9)                           2 (6)
   No                 10 (91)                         29 (94)

Abbreviation: MEP, motor evoked potential.

Note: *p* \> 0.99; sensitivity 33%; specificity 74%.

Intraoperative Motor Evoked Potential Monitoring Performance in Subgroups of Pathologies
----------------------------------------------------------------------------------------

The numbers of patients in each subgroup were too small to statistically analyze. We compared the differences in the performance measures to assess for trends. Within the tumor subgroup, IONM of MEP changes was associated with a sensitivity of 0% and a specificity of 61% ([Fig. 2](#FI1500066-2){ref-type="fig"}). IONM of MEP changes appeared to perform slightly better in the infection subgroup (sensitivity 50%, specificity 100%). As mentioned above, there were significantly more thoracic lesions in the nondegenerative group. To address this discrepancy, we analyzed the cervical cases. There were 96 cervical-only cases in the degenerative group and 19 in the nondegenerative group. Within this subgroup, the observed trend persisted. In the degenerative group, MEP alerts were associated with new neurologic deficits (*p* \< 0.001) ([Table 4](#TB1500066-4){ref-type="table"}), although they were not associated with new deficits in the nondegenerative group (*p* \> 0.05) ([Table 5](#TB1500066-5){ref-type="table"}).

###### Intraoperative MEP alerts and new postoperative neurologic deficits in patients with degenerative lesions in the cervical region

                      MEP alert (*n* = 10), *n* (%)   No alert (*n* = 86), *n* (%)
  ------------------- ------------------------------- ------------------------------
  New motor deficit                                   
   Yes                5 (50)                          1 (1)
   No                 5 (50)                          85 (99)

Abbreviation: MEP, motor evoked potential.

Note: *p* \< 0.001.

###### Intraoperative MEP alerts and new postoperative neurologic deficits in patients with nondegenerative lesions in the cervical region

                      MEP alert (*n* = 5), *n* (%)   No alert (*n* = 14), *n* (%)
  ------------------- ------------------------------ ------------------------------
  New motor deficit                                  
   Yes                0 (0)                          2 (14)
   No                 5 (100)                        12 (86)

Abbreviation: MEP, motor evoked potential monitoring.

Note: *p* \> 0.99.

![Representative intraoperative neurophysiologic motor evoked potential (MEP) monitoring recordings obtained from the patient described in [Fig. 1](#FI1500066-1){ref-type="fig"}. During tumor resection, there was loss of MEP signal in the biceps, abductor pollicis brevis, and flexor hallucis brevis. The abductor pollicis brevis did not recover despite intraoperative measures. Nevertheless, the patient awoke with no new neurologic deficits.](10-1055-s-0035-1565258-i1500066-2){#FI1500066-2}

Discussion
==========

We recently reported high sensitivity and specificity of IONM of MEP alerts in predicting new postoperative deficits in patients undergoing surgery for degenerative CSM.[@JR1500066-9] In the current study, we were interested in examining the association between persistent intraoperative MEP alerts and new postoperative deficits in patients with myelopathy undergoing surgery for compressive, nondegenerative extra-axial lesions. Our data suggests that IONM of MEPs predicts postoperative deficits better in surgery for degenerative compared with nondegenerative myelopathy.

Bias may have been introduced into our study due to the differences in a few preoperative variables between our two study groups, which may have been secondary to a more rapid onset of spinal cord compression (weeks or even days) in nondegenerative pathologies compared with months or years in degenerative conditions. Specifically, more patients had preoperative motor deficits in the nondegenerative cervical myelopathy group. In our prior study of patients with degenerative CSM, we demonstrated significantly increased sensitivity of intraoperative MEP alerts in patients with preoperative motor deficits.[@JR1500066-9] Therefore, it is unlikely that this difference affected the results because increased sensitivity would then be expected in a group of patients with increased rates of preoperative deficits. Likewise, there were higher numbers of women, thoracic lesions, posterior-only operations, and noninstrumented operations in the nondegenerative cervical myelopathy group. These differences were not shown to affect the sensitivity of intraoperative MEP alerts in our previous study, and we do not suspect that these differences introduced significant bias in this study. The thoracic spinal cord is more susceptible to vascular compromise, therefore we chose to perform a subgroup analysis on the cervical cases to see if the trends persisted. In the cervical-only group, MEP alerts remained associated with new deficits in the degenerative group but not the nondegenerative group. Our study is limited by the retrospective nature of the data as well as a small sample size. Future larger studies could potentially be amenable to further subgroup analysis to detect the differences between extramedullary tumor, infection, trauma, and inflammatory processes.

IONM of MEPs is frequently used in spinal deformity surgery. Studies have demonstrated high sensitivity and specificity for detecting neurologic deficit,[@JR1500066-10] [@JR1500066-11] which may be due to lack of preoperative neurologic deficit and cord compression and the defined period of intraoperative time where the risk for neural injury is high in these cases.[@JR1500066-12] IONM of MEPs can be focused during the time of maximal manipulation of neural elements, such as during osteotomy closure. Likewise, IONM of MEPs is associated with very high sensitivity and specificity for spinal cord tumor surgery.[@JR1500066-13] One study demonstrated improved outcomes if IONM was used in conjunction with the tumor resection.[@JR1500066-14] If a change is detected, specific maneuvers can be performed by the surgeon, the neurophysiologist, and the anesthesiologist with the goal of eliciting a return to baseline of IONM of MEP.[@JR1500066-6] [@JR1500066-15] We have recently reported an intraoperative checklist to standardize the rapid response of the entire operating room team to a neuromonitoring alert.[@JR1500066-8]

In contrast, during decompression for cervical myelopathy, the risk to the spinal cord and nerve roots exists throughout the entire decompression procedure and not during a defined short period. IONM can be useful in cervical myelopathy cases, but it appears to be more sensitive and predictive of postoperative deficits in patients with degenerative CSM compared with those with nondegenerative cervical myelopathies. The causes of this difference in sensitivity and PPV of IONM are debatable. Patients with nondegenerative myelopathies often have a more focal lesion causing the cord compression compared with those with degenerative CSM. In addition, degenerative CSM often occurs over a period of time, allowing the spinal cord to adapt slowly to the compressive agents, whereas patients with nondenegerative myelopathy may have more acute cord compression. How these differences affect IONM are not clear at this time, which warrants further study in the future.

Conclusion
==========

We found that IONM of MEPs may be associated with lower performance (decreased sensitivity) in decompressive surgery for patients with myelopathy secondary to nondegenerative, such as extra-axial tumor, infection, trauma, and inflammatory processes, when compared with patients with degenerative CSM. The etiology of the difference in efficacy of MEP monitoring between cases with degenerative CSM and CSM of nondegenerative causes is not understood, and further study on this topic is needed. Surgeons using IONM of MEPs for cases with nondegenerative cervical myelopathy should be aware that the sensitivity and PPV of the modality may be limited in these cases. The value of IONM of MEPs arising from reversible alerts that may have prevented occurrence of permanent postoperative neurologic deficit by altering the surgical procedure could not be assessed in this study and may represent the major justification for IONM of spinal cord function.
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